VN Research & Consulting
 Like us on facebook  Follow us on twitter  Follow us on LinkedIn  IndiaNotes on Google Plus  IndiaNotes on Pinterest  IndiaNotes on Stumbleupon  Subscribe to our feeds

Stocks  A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
You are here: IndiaNotes

Filter search : Quote Research All

Reports for search string : market size

Positional Call: Buy Zee Learn for an upside potential of 32% in 3-months
PAN India presence with aggressive expansion in footprint, enrolment growth in its institutes, asset light business model, increasing capacity utilization and increase share of wallet makes Zee Learn ...
Rudra Shares and Stock Brokers, 18 Jan 2018
Ujjivan Financial Services: Worst is Behind; Well-poised for Profitable Growth
Ujjivan is structurally better placed visà- vis other MFIs and vehicle financing NBFCs on the back of access to low-cost funds and wider scope of cross-selling opportunities following conversion into ...
Reliance Securities, 17 Jan 2018
Pick of the Week: Buy Laurus Labs at CMP and add on declines
At CMP of Rs 524 the stock quotes at 18.2x FY19E EPS. We feel investors could buy the stock at the CM P and add on dips to Rs 472-478 band (16.5x FY19E EPS) for sequential targets of Rs. 590 (20.5x FY...
HDFC Sec, 18 Dec 2017
Glenmark Pharmaceuticals: First DPI Inhaler approval in EU a foot forward; Accumulate
Maintain ‘Accumulate, TP at 733: With market size of USD150-200m in gSeretide DPI, Nordic region is mainly a tender market as social healthhcare cost is borne by the governments. While the prodcut app...
Prabhudas Lilladher, 04 Dec 2017
Rudra Shares recommend Dynemic Products as a dark horse
The food colors market size is projected to reach USD 3.75 Billion by 2022, to grow at a CAGR of 8.40% from 2016. With increasing use of food colors and food grade additives in the developed countries...
Rudra Shares and Stock Brokers, 28 Nov 2017
Granules India Q2FY18: Omnichem JV to ramp-up in rest of fiscal; go Long
Granules India’s (GRAN) 2QFY18 sales/EBITDA/PAT (before JV profits) at 3.93bn/ Rs 769mn/Rs 355mn were largely in line with EE. However, PAT post JV profits (Rs 403mn) was 21% lower on deferred supplie...
Equirus Securities, 20 Nov 2017
Relaxo Footwears: A value for money investment
The management is planning to expand faster using the franchise model. FY17 was flat financially on account of demonization led disruption and higher expenses. The margins and volumes are both likely ...
Punit Jain, 10 Nov 2017
Mahindra Logistics : Non Mahindra clients growing higher than Mahindra; Subscribe
Over, FY15- FY17 the company sales has grown at a CAGR of 17.5% wheras the Non Mahindra revenue has grown at a CAGR of 45.9% during the same period and form 44.5% of revenue in FY17. We recommend su...
Nirmal Bang, 31 Oct 2017
Stock in focus: Buy Majesco with a target price of Rs...
Majesco Limited’s stock rose by 6.1% yesterday, while the BSE Sensex rose 0.4%. Industry fundamentals and the key IBM partnership will enable Majesco to boost revenue growth going forward. We current...
Reliance Securities, 29 Sep 2017
SMC's weekly sector updates
SMC, in its weekly news highlights the latest developments in each sector that happened during the week. It also throws some light on some key International events.
SMC, 24 Jul 2017
GIC Hsg Fin: CD Equisearch assign 'accumulate' rating with a revised target
According to CD Equisearch, the stock currently trades at 3.1x FY18e BV (16.7x FY18e EPS of Rs 33.14) and 2.7x FY19e BV (13.7x FY19e EPS of Rs 40.40). On balance, we assign 'accumulate' rating on the ...
CD Equisearch Pvt Ltd, 20 Jul 2017
S Chand IPO: An Educational Content Powerhouse
JainMatrix Investments are rating the S Chand and Company IPO as BUY with a 2-year investment perspective. They believe that at a PE of 36.8 TTM, valuations are expensive. But, debt can be reduced pos...
Punit Jain, 27 Apr 2017
IPO Note: S Chand & Company - HDFC Securities
The Offer comprises of the Fresh Issue and the Offer for Sale. Company will not receive any proceeds from the Offer for Sale. It proposes to utilise the Net Proceeds from the Fresh Issue towards Repay...
HDFC Sec, 24 Apr 2017
Cadila Healthcare: Achiievers Equities initiate coverage with 'Buy' rating and target implying 11% upside
We believe Cadila is well positioned to leverage the volume-driven growth in the domestic pharma space given its new product launches, penetration into tier II towns & increasing sales force productiv...
Achiievers Equities, 24 Mar 2017
Vinati Organics: CD Equisearch revise their rating to 'Hold', holding period of 6-9 months
According to CD Equisearch, the stock presently trades at 30.1x FY17e EPS of Rs. 25.64 and 27.1x FY18e EPS of Rs. 28.44. They are revising their rating to 'Hold' with a target based on 25x FY18e earni...
CD Equisearch Pvt Ltd, 22 Feb 2017
Excel Crop Care: Buy for an upside of 28% in 1 year
Estimating the share price of the company as per P/E valuation, and putting the estimated P/E of FY18E at 30x & the estimated EPS at Rs 74.87, Rudra Shares are estimating the share price for the next ...
Rudra Shares and Stock Brokers, 14 Feb 2017
Why one should convert newly started small business enterprise into a start-up
It is necessary to understand the difference between Start-up and Small Business Enterprises. Most newly started ventures struggle to get funds because on founders mind they are startup but on paper t...
Gaurav Barick, 13 Feb 2017
Aurobindo Pharma: Valuation gap will narrow going forward
Way2wealth believe the valuation gap will narrow going forward on the back of the company's strong US portfolio, synergies from recent acquisition & improving earnings visibility. At its CMP of 704.55...
Way2wealth, 12 Jan 2017
Blue Dart Express: Recent correction has made the stock available at reasonable valuations
According to Way2wealth, going ahead, we expect the economy to gather steam. We believe the recent correction is on the back of FY17 being a year of consolidation for the company. This has made the st...
Way2wealth, 03 Jan 2017
Motilal Oswal recommend Top Picks for 2017
Motilal Oswal are recommending Top Picks for 2017. They include APL Apollo Tubes, Sterling Tools, Canfin Homes, ICICI Bank and Tata Motors. They are also sharing with us the respective upside potentia...
Motilal Oswal, 02 Jan 2017
View All

Intraday Tips

What are technical calls?
* SEBI certified analyst

View Stock Advice by: